Abstract
Acute pancreatitis (AP), which is characterized by self-digestion of the pancreas by its own prematurely activated digestive proteases, is a major reason for hospitalization. The autodigestive process causes necrotic cell death of pancreatic acinar cells and the release of damage associated molecular pattern which activate macrophages and drive the secretion of pro-inflammatory cytokines. The MYD88/IRAK signaling pathway plays an important role for the induction of inflammatory responses. Interleukin-1 receptor associated kinase-3 (IRAK3) is a counter-regulator of this pathway. In this study, we investigated the role of MYD88/IRAK using Irak3−/− mice in two experimental animal models of mild and severe AP. IRAK3 is expressed in macrophages as well as pancreatic acinar cells where it restrains NFκB activation. Deletion of IRAK3 enhanced the migration of CCR2+ monocytes into the pancreas and triggered a pro-inflammatory type 1 immune response characterized by significantly increased serum levels of TNFα, IL-6, and IL-12p70. Unexpectedly, in a mild AP model this enhanced pro-inflammatory response resulted in decreased pancreatic damage, whereas in a severe AP model, induced by partial pancreatic duct ligation, the increased pro-inflammatory response drives a severe systemic inflammatory response syndrome (SIRS) and is associated with an increased local and systemic damage. Our results indicate that complex immune regulation mechanism control the course of AP, where moderate pro-inflammation not necessarily associates with increased disease severity but also drives tissue regenerative processes through a more effective clearance of necrotic acinar cells. Only when the pro-inflammation exceeds a certain systemic level, it fuels SIRS and increases disease severity.
Similar content being viewed by others
Introduction
Acute pancreatitis (AP) is the gastrointestinal disorder with the highest rate of hospital admissions among all non-malignant GI diseases. While 80% of patients have a self-limiting mild course of the disease, in 20% the disease takes a more severe course, characterized by systemic complications such as organ failure or infection of pancreatic necrosis. The major driving factor of severity is an exaggerated immune response1,2,3,4. Development of a systemic inflammatory response syndrome (SIRS) is common in severe AP patients. Macrophages/monocytes are the most numerous cells of the immune system which migrate into the inflamed organ3,5 and get activated by cytokines or damage associated molecular patterns (DAMPs) that are released by damaged acinar cells. The release of other cytokines, such as TNFα3,6, amplifies acinar cell damage and creates a self-fuelling cycle of necrosis driven inflammation.
Toll-like receptor (TLR) mediated activation of immune cells is mainly mediated by the MYD88/IRAK/NFκB cascade7. IRAK3 is an endogenous counter regulator of the TLR/MYD88 signalling, in order to prevent hyperinflammation8. TLRs detect a variety of pathogenic signalling molecules like bacterial lipopolysaccharides (LPS). Remarkably, AP is a primarily sterile inflammation, but beside PAMPs (pathogen associated molecular pattern) TLRs are also able to recognise multiple DAMPs (damage-associated molecular pattern) such as free DNA, free ATP or intracellular proteins released by necrotic cells9,10. Necrotic cell death is the dominant form of cell death during pancreatitis11. A second sensor axis for the detection of damage is the IL-1 Receptor signalling, which also involves the MYD88/IRAK/NFκB cascade. The IL-1 receptor family detects cytokines of the IL-1 cytokine family including “alarmins” like IL-1α or IL-33 which are also released during necrotic cell death12.
The severity of the AP course is believed to depend on the strength of the induced immune response which determines the course and prognosis of the disease. The TLR/IL-1R signalling pathway plays a critical role in translating local damage into a systemic immune response13. The aim of this study was to investigate the regulation of the immune response in relation to the role of the endogenous inhibitor IRAK3 in two mouse models of mild and severe acute pancreatitis.
Results
AP causes activation of the MYD88/IRAK3 signalling pathway in macrophages
AP was induced in C57BL/6 mice by hourly injections of caerulein. Analysis of AP-induced TLR4 signalling in CD11b+ cells, which were isolated from murine pancreatic tissue, showed significantly increased labelling of the TLR4/MD2 complex (Fig. 1A). PCR analysis of the Irak3 gene, encoding the IRAK3 protein, showed in pancreatic tissue a significantly increased mRNA level 8 h after the onset of the disease (Fig. 1B). IRAK3 is mainly expressed in macrophages where it acts as a negative regulator of TLR and IL1R signalling pathways. Co-incubation of bone marrow derived macrophages (BMDMs) with acinar cells, previously stimulated for 30 min with 0.001 mM CCK, showed a significantly increased Irak3 gene expression in macrophages in response to their exposition to damaged acini (Fig. 1C). In a Co-incubation experiment of CCK-stimulated acinar cells with BMDMs from IRAK3 deficient mice we saw a significant higher expression of pro-inflammatory genes, such as Tnfa, Il6, Nos2 and Il12b which are under the transcriptional control of NFκB (Fig. 1D). Also, the co-incubation with CCK-stimulated acinar cells caused a significantly increased release of TNFα and IL-6 into the medium (Fig. 1E).
The AP-induced systemic immune response is increased in IRAK3 deficient mice
AP was induced by hourly injections of caerulein in wild type and Irak3−/− mice. We valuated myeloperoxidase activity in lung tissue as an indicator of a systemic immune response and found a significant increase in the IRAK3 deficient mice. H&E staining confirmed the involvement of the respiratory tissue in the immune response (Fig. 2A). The levels of pro-inflammatory cytokines IL-12p70 and TNFα, as well as the chemokine MCP-1 were significantly elevated in IRAK3 deficient mice, (Fig. 2B). IL-12p70 is known to induce in T-cells a Th1-cell differentiation. Flow cytometry analysis of splenocytes from these mice showed a significantly increased activation of CD4+ T-helper cells in Irak3−/− mice after induction of AP. The cell surface expression of T-cell activation markers CD25 and CD69 were significantly increased in Irak3−/− 8 h after onset of pancreatitis (Fig. 2C,D). Also, a significantly induced differentiation of T-cells towards a pro-inflammatory Th1 phenotype could be observed by intracellular labelling of the transcription factor TBET (Fig. 2E).
Knockout of IRAK3 improves the outcome of AP
Analysis of pancreas histology showed a significantly reduced pancreatic damage in the IRAK3 deficient animals 8 h after onset of the disease (Fig. 3A), and especially the number of necrotic acinar cells was significantly reduced. (Fig. 3B). Beside necrotic cell death, also the number of apoptotic acinar cells was significantly reduced in the IRAK3 deficient mice, as was shown by the reduced number of TUNEL (TdT-mediated dUTP-biotin nick end labelling) positive cells in the pancreas (Fig. 3C). Serum Lipase activity, a biomarker of pancreatic damage, was significantly reduced in the Irak3−/− mice and confirmed our histological observations (Fig. 3D). Intrapancreatic trypsinogen activation was not different between wild type and IRAK3 deficient mice during the time course of caerulein induced pancreatitis (Fig. 3E). To investigate a direct effect of the Irak3 knockout on the acinar cell response to caerulein, we isolated acinar cells from wild type and IRAK3 deficient mice, stimulated them with 0.001 mM CCK for 0 min, 20 min, 40 min and 60 min and measured intracellular trypsinogen activation, as well as necrotic cell death development by PI uptake. Acinar cells from both mouse strains responded in the same way to CCK (Fig. 3F).
The local pancreatic immune response is elevated in IRAK3 deficient mice
To evaluate the local pancreatic immune response during pancreatitis, we labelled tissue sections with CD68 and CCR2 to identify pancreatic macrophages and infiltrating monocytes. Here we observed a significantly increased number of CD68+ macrophages in the pancreas of IRAK3 deficient mice after induction of AP (Fig. 4A,B). These cells were mainly positive for the chemokine receptor CCR2, which binds MCP-1 and recruit’s monocytes to the site of inflammation. It is known that pro-inflammatory macrophages can contribute to the pancreatic damage via the release of TNFα3,6,14, but we observed significant less acinar cell necrosis (Fig. 3A,B). Phagocytosis assays with bone marrow derived macrophages from wild type and Irak3−/− mice showed a higher phagocytosis ratio in the IRAK3 deficient cells (Fig. 4C,D) which suggests a faster clearance of pancreatic necrosis in the Irak3−/− mice.
IRAK3 mediated TLR signalling is active in pancreatic acinar cells
We observed less tissue damage and a diminished disease severity in Irak3−/− mice in the presence of an increased pro-inflammatory immune response, which suggests a protective role of the MYD88/IRAK/NFκB pathway. Investigation of NFκB activation in pancreatic tissue showed significantly increased nuclear translocation of NFκBp65 in the Irak3−/− mice (Fig. 5A,B). In the next step we analysed Toll-like receptor expression in pancreatic acinar cells. Especially the expression of Tlr2, Tlr3, Tlr4 and Tlr9 mRNAs could be detected in acinar cells of wild type mice (Fig. 5C). Also, counter regulating IRAK3 could be detected in isolated acinar cells and showed an increased expression 2 h after stimulation with 0.001 mM CCK (Fig. 5D). These data make a direct effect of the IRAK3 deficiency on acinar cells likely. It is known that increased NFκB activation in pancreatic acinar cells leads to an elevated anti-stress response and ameliorates disease severity15.
In a severe AP model a higher local pro-inflammatory response causes increased local damage
To compare the results from the model of caerulein-induced mild pancreatitis with a more severe disease model, we induced AP by partial ductal ligation in mice. This model of AP causes a severe necrotizing form of pancreatitis5,16, associated with infected necrosis4 and organ damage2. H&E staining of pancreatic tissue sections demonstrated the severe necrotizing pancreatitis. In contrast to the model of caerulein induced pancreatitis, the degree of tissue damage was significantly higher in Irak3−/− mice compared to wild type mice (Fig. 6A). Measurement of serum lipase activity confirmed this observation and was significantly increased in Irak3−/− mice (Fig. 6B). The numbers of CD68+ and CCR2+ cells in pancreas were also increased in the IRAK3 deficient mice, which suggest a more prominent local inflammatory response in the absence of IRAK3 (Fig. 6C,D). The overall response is comparable but stronger than in the caerulein induced AP (Fig. 4A,B). Measurement of serum cytokine levels of IL6, TNFα and IL12p70 were significantly higher in the Irak3−/− mice (Fig. 6E).
Knockout of IRAK3 increases the systemic inflammation in a severe AP model
The systemic inflammatory response was investigated by flow cytometry analysis of CD4+ T-cells in spleen. We observed in severe pancreatitis an increased T-cell activation marked by the elevated cell surface expression of CD25 and CD69 on T-helper cells. This T-cell activation was significantly higher in the IRAK3 deficient mice (Fig. 7A). Only the T-cells from the spleen of Irak3−/− mice showed a significantly elevated level of TBET+ Th1-cells, whereas wild type mice showed no such signs of a Th1 response (Fig. 7B). Measurements of MPO activity in lung revealed no differences between the mice strains (Fig. 7C). SAP induced via partial pancreatic duct ligation is associated with respiratory dysfunction which could be measured by quantification of the alveolar space in histological sections2. In contrast to the lung MPO data we observed a significantly reduced lung volume in IRAK3 deficient mice after induction of SAP (Fig. 7D). Measurement of the C-reactive protein (CRP) in serum, a clinical diagnostic marker of inflammation, showed no dramatic increase in caerulein induced pancreatitis. Notably, IRAK3 deficient mice showed significant higher serum levels of CRP in the model of partial duct ligation. High CRP levels indicate the induction of SIRS, which is known to associate with a more severe disease course (Fig. 7E). A comparative summary of both models shows an increased systemic and local pro-inflammatory response in general, but with different outcome concerning pancreatic damage. Whereas the milder inflammatory response does not elevate the disease severity in the model of caerulein induced AP, the markedly elevated inflammatory response in the partial pancreatic duct ligation model was associated with significantly increased disease severity (Fig. 7F). These results suggest a dose dependent disease driving mechanism of pro inflammation.
Discussion
Acute pancreatitis is characterized by a pronounced pro-inflammatory immune response that may develop into systemic inflammatory response syndrome (SIRS), increased pancreatic damage and systemic complications such as organ failure1,2,4,16. A crucial role for the induction of the immune response play Toll-Like and IL-1 receptor-signalling pathways13,17,18. Both pathways activate the MYD88/IRAK cascade, which results in the activation of transcription factor NFκB19. MYD88 is present in a complex with IRAK1/2 and IRAK4 which transmits TRAF6-mediated activation of the transcription factor NFκB in a phosphorylation-dependent manner. IRAK3 is a counter regulator of this signalling pathway, IRAK3 prevents dissociation of the IRAK-TRAF6 complex from the myddosome and thus prevents phosphorylation of NFκB8,20. IRAK3 is mainly expressed in macrophages, and regulates cytokine production through its inhibitory function21.
During acute pancreatitis, a pronounced pro-inflammatory immune response can occur, which further increases the local organ damage3,22 and is responsible for the development of systemic complications1,2,4. Our results from the mild model of caerulein-induced pancreatitis in Irak3−/− animals show that a limited degree of pro-inflammation may however be beneficial for tissue integrity, by clearance of necrotic cells and damaged tissue, and is not necessarily associated with increased severity. It is known that a prolonged clearance of necrosis is associated with extended inflammation and impaired regeneration23. Despite increased macrophage infiltration of the pancreas and observable systemic immune responses, the local pancreatic damage was significantly lower in IRAK3 deficient mice. In addition to macrophages pancreatic acinar cells also express IRAK3 and a repertoire of Toll-like receptors that likewise stimulate NFκB activation in acinar cells. NFκB activation occurs rapidly in acinar cells and forms the cornerstone of the immune response during pancreatitis24. Notably, a pancreas-specific deletion of the RelA the p65 subunit of NFκB did not attenuate inflammation and reduce disease severity but resulted in dramatically increased pancreatic damage and pro-inflammation25. On the other hand, increased activation of RelA by deletion of the inhibitor IκBα was protective during AP15. NFκB regulates not only the expression of inflammatory genes, but also of various stress response and survival genes that are protective and limit the organ damage15. Following induction of mild AP we observed significantly increased NFκB nuclear localization in Irak3−/− mice indicating an elevated anti-stress response that can help to decrease acinar cell damage. In addition, macrophages of IRAK3 deficient mice showed a higher phagocytosis ratio, which suggests an accelerated clearance of necrotic cell debris in the pancreas.
The clearance of necrotic cells is a necessary first step for the initiation of tissue regeneration after pancreatitis. On the one hand, rapid phagocytosis of necrotic cells prevents the spread of necrosis23,26. Necrotic cells release high amounts of ROS, which in turn aggravates the tissue damage26. On the other hand, enhanced clearance limits the release of DAMPs, leading to a decreased polarization of surrounding macrophages towards a pro-inflammatory phenotype5,27. Thus, rapid clearance of tissue damage helps to prevent necrosis from spreading and may attenuate disease severity and progression. Tissue fibrosis is another major feature of regeneration after AP or acute relapse during chronic pancreatitis. In a necrosis/fibrosis sequence cleared necrotic tissue is replaced by extracellular matrix proteins and thus directly correlates the number of necrotic cells with the induced fibrogenesis28,29. Therefore, rapid clearance of necrosis can influence the subsequent regeneration process. However, IRAK3 is also involved in the type 2 immune response and can trigger fibrogenesis directly via the IL-33 ST2 axis on Th2 and ILC2 cells.29,30. The deletion of IRAK3 could therefore also have a direct effect on the tissue fibrosis.
As a second model of pancreatitis, we induced a more severe form of the disease by partial pancreatic duct ligation2,4,5,16,28. Here we observed an aggravating effect of the IRAK3 deletion, contrary to the mild model of caerulein induced pancreatitis. The model of SAP induced by partial duct ligation resulted in a prominent immune response, driven by pro-inflammatory macrophages5,31. In contrast to the caerulein induced pancreatitis, an increased anti-stress response cannot overcome the disease-causing blockade of the duct. Therefore, the activation of the MYD88/IRAK signalling pathway in immune cells can play a more prominent role, which triggers markedly elevated inflammatory markers and increased local and systemic damage. These results suggest a cell specific effect of the TLR/MYD88/IRAK pathway. Whereas the MYD88/IRAK pathway activates in acinar cells a damage-limiting anti-stress response15,32, the same pathway leads in cells of the innate immune system to an increased pro-inflammatory response8. In the severe model of AP, pro-inflammation reaches a systemic level, accompanied by a cytokine storm and severity driving SIRS, whereas a limited pathway activation enhances the clearance of pancreatic necrosis and does not necessarily result in a systemic hyperinflammation. Apparently, it is not only relevant in which cells NFκB is activated, but the level of activation in immune cells also plays an important role in determining the severity of pancreatitis. Our study demonstrated the complex nature of the immune response during AP and proves that a moderate pro-inflammation may be necessary to resolve the pancreatic damage. To investigate in more detail the cell specific influence of IRAK3 in acinar cells, macrophages or other immune cells, experiments in conditional knockouts using cell-specific promoter systems such as the Cre-Lox system would be helpful. This would allow us to distinguish between the TLR/MYD88/IRAK signalling effect of IRAK3 deficiency in pancreatic acinar cells and in myeloid cells like macrophages.
Beside the local pancreatic damage, AP induced in both models an increased systemic response. Lung MPO activity or decreased alveolar space could be observed in Irak3−/− mice as well as elevated serum levels of pro-inflammatory cytokines like IL6, which is known to be involved in pancreatitis mediated lung damage33. Recent data have shown that the deletion of TLR4 in the intestine leads to severe gut dysbiosis associated with increased disease severity during caerulein induced pancreatitis34. IRAK3 is known to influence the microbiome by regulating mucosal defence mechanisms35 and to prevent bacterial translocation into pancreatic necrosis4, the most significant risk factor for disease outcome36. These data suggest that in addition to the local immune response also the systemic immune reactions like in spleen16, duodenal mucosa4, lung33 and kidney2 affect disease severity and the prognosis of AP.
In conclusion, our data revealed the two faces of the pro-inflammatory immune response during AP. On the one hand increased NFκB activation in acinar cells strengthens anti-stress response mechanisms and ameliorates the local damage15,25. A moderate pro-inflammation also stimulates macrophages to clear necrotic areas. On the other hand strong NFκB activation in pancreatic macrophages results in uncoupled pro-inflammation characterized by SIRS and is associated with increased systemic damage5,16,27. Our study suggests that the systemic response is not a direct consequence of the local pancreatic damage but is rather determined by the (local) activation of immune cells.
Material and methods
Antibodies and reagents
Cholecystokinin CCK-8 (Sigma Aldrich, C2901), Collagenase of Clostridium histolyticum (EC.3.4.24.3) from (Serva, lot no. 14007), MCSF (BioLegend, Cat.576406), anti-NFκBp65 (Cell signaling, 8242), CD68 (antibody-online, ABIN181836), CCR2 (abcam, ab273050), TLR4/MD2 (BioLegend PE/Cy7 Cat. 117610), CD11b (BioLegend PerCP/Cy5.5 Cat.101228), CD69 (BioLegend BV510 Cat.104531), TBET (BioLegend PerCP/Cy5.5 Cat. 644805), CD25 BioLegend PE/Cy7 Cat. 102015), CD4 (BioLegend PE Cat. 100408), anti-α-amylase (Santa Cruz, sc-46657).
Animal model
Irak3−/− mice (B6.129S1-Irak3tm1Flv/J) were obtained from JaxMice and were bred in the central animal facility of the university medicine Greifswald. C57BL/6-J mice were obtained from Charles River (Sulzfeld, Germany). All mice were maintained under pathogen-free conditions in ventilated animal cabinets with a 12 h light–dark cycle at a temperature of 21–24 °C (humidity 50–70%) and with access to food and water ad libitum. 8–12 weeks old male or female mice were used for the experiments. AP was induced by hourly intraperitoneal injections of caerulein (4030451, Bachem) (50 µg/kg/bodyweight) to a maximum of 8 h3. AP animals were sacrificed 1 h and 8 h after the first caerulein injection. SAP was induced by partial duct ligation followed by a single injection of caerulein 48 h after surgery, as previously described2,4,5,16,28. The mice were anesthetized with ketamine/xylazine, the peritoneal cavity was surgically opened, and the pancreas was exposed. A severe acute form of pancreatitis was induced by ligation of the pancreatic duct at the junction between the gastric and the duodenal lobe like previously described. The animals receive a single i.p. injection of caerulein (50 μg/kg/body weight) 48 h after surgical duct ligation. The mice were sacrificed 24 h after the caerulein injection (72 h after surgical duct ligation).
Ethics declaration
All animal experiments were previously approved by an animal care committee (Landesamt für Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklenburg-Vorpommern LALLF-7221.3-1-011/17) and performed in accordance to the national guidelines for animal experiments. All animal experiments were performed in accordance to the ARRIVE guidelines.
Isolation of bone marrow derived macrophages (BMDMs)
Myeloid progenitor cells were isolated from the bone marrow of mice (femur and tibia) and were cultivated in RPMI medium containing 5% fetal calf serum and PenStrep in the presence of 20 ng/mL macrophage colony-stimulating factor (M-CSF) for the differentiation into macrophages. Cells were maintained over 5–7 days until confluency. Macrophages were co-incubated with freshly prepared acini for 6 h. Phagocytosis was measured by Phagocytosis Assay Kit (IgG PE) from Cayman Chemicals (cat. 600540, Ann Arbor, MI USA), using a fluorometer (FLUOstar Optima from BMG Labtech, Ortenburg germany) or by flow cytometry (BD, LSRII).
Isolation of pancreatic acinar cells
Acinar cells were freshly prepared by collagenase digestion under sterile conditions in the presence of PenStrep3,37. The pancreas was removed carefully and transferred into Dulbecco’s modified Eagle medium containing 2% bovine serum albumin and 10 mM HEPES in the presence of 1 mg collagenase and 1% PenStrep. Acinar cells were stimulated with 0.001 mM cholecystokinin (CCK) for 30 min and washed carefully before co-incubation with BMDMs. Intracellular enzyme measurement and necrosis detection was performed in living acinar cells. Cells were isolated as previously described and stimulated with CCK up to 60 min. Intracellular trypsin activity was measured against a fluorogenic substrate (R110-Ile-Pro-Arg) in a kinetic series for 60 min. Necrosis was determined by propidium iodide uptake. Both were measured by fluorometer (FLUOstar Optima from BMG Labtech, Ortenburg Germany) at 37 °C in medium (pH 7.4) containing 24.5 mm HEPES, 96 mm NaCl, 11.5 mm glucose, 6 mm KCl, 1 mm MgCl2 6H2O, 0.5 mm CaCl2 2H2O, 2.5 mm NaH2PO4 H2O, 5 mm sodium fumarate, 5 mm sodium glutamate, 5 mm sodium pyruvate, and 1% BSA and DMEM.
Myeloperoxidase measurement
MPO activity was determined as described previously3,5. Lung tissue was homogenized in 20 mM potassium phosphate buffer (pH 7.4) on ice and centrifuged. The pellet, containing the neutrophils and monocytes, was resuspended in 50 mM potassium phosphate buffer (pH 6.0) containing 0.5% cetyltrimethylammoniumbromide. The suspension was frozen/thawed in 4 cycles, sonicated, and centrifuged at 20,000g. Myeloperoxidase activity was measured in 50 mM potassium phosphate buffer (pH 6) containing 0.53 mM O-dianisidine and 0.15 mM H2O2 as kinetic over time with a Spectramax (Molecular Devices, San Jose, CA USA) Spectrophotomenter. MPO activity was calculated against protein content of lung tissue homogenate.
CRP and Cytokines determination in serum and supernatant
IL-12p70, IL-6, MCP-1, and TNFα were measured in serum samples of mice and cell culture supernatant by Cytometric Bead Array (CBA) Mouse inflammation kit (cat. 552,364 BD Bioscience, San Jose, CA USA). Concentration of C-reactive protein in serum was determined by Mouse C-Reactive Protein/CRP DuoSet ELISA (R&D Systems, Minneapolis, MN USA).
Histology
Paraffin sections were used for hematoxylin and eosin staining. Slides were scanned and digitally stored with a slide scanner (Pannoramic MIDI BF/FL, Sysmex Norderstedt, Germany). Histology severity scoring was performed according to Niederau et al.38. Acinar cell necrosis, oedema, infiltration and vacuolization were quantified in a blinded manner. Quantification of alveolar space in lung slides was performed by Quant centre software from Sysmex as previously described2.
Apoptosis assay
Quantification of apoptotic cells was performed by TUNEL assay (FragEL™ DNA fragmentation detection kit from Millipore, catalog no. QIA39–1EA) using paraffin sections. Slides were scanned with slide scanner (Pannoramic MIDI BF/FL, Sysmex Norderstedt, Germany). Quantification of apoptotic cells was performed by Quant centre software from Sysmex, TUNEL positive cells were calculated against total cell number37.
Immunofluorescence labelling
Immunofluorescence labelling of CD68 and CCR2 was performed on 2 µm cryo slides, labelling of NFκBp65 and α-amylase was performed on 2 µm paraffin slides. The primary antibodies were used in a 1:100 dilution and incubated over night at 4 °C. The secondary antibodies were used in a 1:200 dilution, for 1 h at room temperature. Nuclear staining was performed by DAPI. Slides were scanned by slide scanner (Pannoramic MIDI BF/FL, Sysmex Norderstedt, Germany). Quantification of positive cells was performed by Quant centre software from Sysmex, positive cells were calculated against total cell number.
Lipase activity
Activity of pancreatic lipase was determined as photometric assay (Photometer: Spectramax plus, molecular devices) in serum by P-Lip-Kit (cat. 03029590, Roche Diagnostic, Mannheim Germany) according to the manufacturers protocol.
Trypsin activity
Trypsin activity was determined in pancreas homogenate. Protease activity measurement was determined as kinetic over 60 min at 37 °C. Activity was measured in buffer containing 100 mM TRIS and 5 mM CaCl2 and 10 µM of the fluorogenic substrate (R110 Ile-Pro-Arg)37. Trypsin activity was calculated against protein content.
Flow cytometry
The Spleen was removed and homogenized directly after sacrificing the mice by using a 70 µm cell strainer. Splenocytes were washed with PBS and centrifuged at 300×g for 6 min. The cell pellet was resuspended in 1 mL erythrocyte lysis buffer, containing: 150 mM NH4Cl, 10 mM KHCO3, 10 mM EDTA ∙ 2Na. After 5 min the reaction was terminated by PBS.
Isolation of leukocytes from pancreatic tissue was performed by using Multi Tissue Dissociation Kit 1 (130-110-201, MiltenyiBiotec) as previously described29. The pancreas was homogenized with the gentleMACS Dissociator (130-093-235, MiltenyiBiotec) at 120 runs for 37 s. After incubation at 37 °C for 20 min under continuous rotation the samples were again dissociated at 168 runs for 37 s. The remaining acinar cells were removed by filtration through a 70 µm cell strainer. The cell suspension was centrifuged at 300×g for 6 min.
Cells were washed with FACS buffer (0.02% sodium azide, 2% FCS, 2 mM EDTA in 1 × PBS), 1 × 106 cells per tube were pre-incubated with 1 µL FcR Blocking Reagent (130-092-575, MiltenyiBiotec) to block non-specific Fc-mediated interactions. In the next step, extracellular markers (1:50 CD4, CD69 and CD25; 1:50 CD11b, TLR4 MD2) were labelled by adding the antibody cocktail and incubated at 4 °C for 30 min. After fixation and permeabilization (Transcription Factor Staining Buffer Set, 130-122-981, Miltenyi Biotec; Fixation Buffer, 420,801, BioLegend) the cell suspensions were again treated with FcR Blocking Reagent and labeled with the intracellular antibody against the transcription factor TBET. Finally, the samples were analyzed by flow cytometry (BD, LSRII), the results were analysed by FlowJo.
PCR and real time PCR
Total RNA was extracted from pancreas, acinar cells and BMDMs using TRIzol Reagent (15596026, life technologies). Samples were homogenized in 500 µL TRIzol and with a TissueLyser. After the addition of 100 µL Chloroform, samples were mixed and centrifuged at 22,000×g, 15 min at 4 °C. Subsequently, the RNA containing phase was transferred to a new tube. RNA was precipitated by adding 250 µL isopropyl alcohol. The sample was incubated for 10 min at RT and centrifuged at 22,000×g, 10 min, 4 °C. The pellet was washed with 500 µL 75% ethanol and again centrifuged at 6500×g for 10 min at 4 °C. After air-drying the pellet was solved in 100 µL A. dest.
RNA samples (2 µg) were transcribed into complementary DNA (cDNA). The cDNA was synthesized using a standard protocol: 2 µg RNA; 5 µM OligodT primers; 75 ng random primers; 0.5 µM dNTP Mix; 1 × First Strand Buffer (18080044, Invitrogen); 10 µM DTT; 40 Units RNasin Ribonuclease Inhibitor (N251B, Promega) and 200 Units M-MLV RT (28025013, invitrogen). The total volume per reaction was 20 µL.
The expression of genes of interest was analyzed by reverse transcription-quantitative PCR (RT-qPCR) using the SYBR-green method. The qPCR amplification was performed in a volume of 5 µL containing 1 × SYBR Green PCR Master Mix (4309155, applied biosystems), 300 ng gene-specific oligonucleotide primers (reverse and forward) and a 1:10 dilution of cDNA fragments in two technical replicates. Detectedtranscript levels were normalized to Rn5s and to the relative expression in control mice. Quantitative mRNA alterations were determined using the 2−∆∆Ct-method as previously described4,29.
Primer
Tlr1 forward 5′-GCTGGTGTTAGGAGATGCTTAT-3′ reverse 5′-GACGGACACATCCAGAAGAAA-3′, Tlr2 forward 5′-TGAAGTCCAGCAGAATCAATACA-3′ reverse 5′-CCGAACCAGGAGGAAGATAAAC-3′, Tlr3 forward 5′-GTGCATCGGATTCTTGGTTTC-3′ reverse 5′-GACCCAGTCTCTGTCTTTATGG-3′, Tlr4 forward 5′-GCTTACACCACCTCTCAAACT-3′ reverse 5′-ACAGCCACCAGATTCTCTAAAC-3′, Tlr5 forward 5′-GAAGACTGCGATGAAGAGGAAG-3′ reverse 5′-CAAGGGTGATGACGAGGAATAG-3′, Tlr6 forward 5′-GGGTAAATCCTCCACCATTCAG-3′ reverse 5′-GCTAACATGAAGCCAGGTAGAG-3′, Tlr7 forward 5′-AACCTTTCCCAGAGCATACAG-3′ reverse 5′-GGAGCCTCTGATGAGACAAATAA-3′, Tlr8 forward 5′-CCTCTCTAAGGCTAGGGTAACT-3′ reverse 5′-TGCCCAGAAGACAGCATTT-3′, Tlr9 forward 5′-TGGACGGGAACTGCTACTA-3′ reverse 5′-CAGAGACAGATGGGTGAGATTG-3′, Irak3 forward 5′-GTGATCATGGAGGTTCTAACGG-3′ reverse 5′-GAGGACAGGGTGGTATCT-3′, Nos2 forward 5′-TTGGAGCGAGTTGTGGATTTG-3′ reverse 5′-TAGGTGAGGGCTTGGCTGAG-3′, Tnfa forward 5′-GCCTCCCTCTCATCAGTTCTAT-3′ reverse 5′-CACTTGGTGGTTTGCTACGA-3′, Il6 forward 5′- CCAGAGTCCTTCAGAGAGATACA-3′ reverse 5′-CCTTCTGTGACTCCAGCTTATC-3′, Il12b forward 5′-AGCACGGCAGCAGAATAAA-3′ reverse 5′-CTCCACCTGTGAGTTCTTCAAA-3′, Rn5s forward 5′-GCCCGATCTCGTCTGATCTC-3′ reverse 5′-GCCTACAGCACCCGGTATTC-3′.
Software
Flow cytometry was analysed by FlowJo Software (BD Biosciences). All graphs were prepared by GraphPad Prism and SigmaPlot. Histology was evaluated by Quant centre software from Sysmex. Bubble chart was prepared by R Studio.
Data availability
All data generated or analysed during this study are included in this published article.
References
Garg, P. K. & Singh, V. P. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology 156, 2008–2023. https://doi.org/10.1053/j.gastro.2018.12.041 (2019).
Wilden, A. et al. Mobilization of CD11b+/Ly6chi monocytes causes multi organ dysfunction syndrome in acute pancreatitis. Front. Immunol. 13, 991295. https://doi.org/10.3389/fimmu.2022.991295 (2022).
Sendler, M. et al. Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut 62, 430–439. https://doi.org/10.1136/gutjnl-2011-300771 (2013).
Glaubitz, J. et al. Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis. Gut https://doi.org/10.1136/gutjnl-2022-327448 (2023).
Sendler, M. et al. Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice. Gastroenterology 154, 704-718.e10. https://doi.org/10.1053/j.gastro.2017.10.018 (2018).
Perides, G. et al. TNF-alpha-dependent regulation of acute pancreatitis severity by Ly-6C(hi) monocytes in mice. J. Biol. Chem. 286, 13327–13335. https://doi.org/10.1074/jbc.M111.218388 (2011).
Takeda, K. & Akira, S. TLR signaling pathways. Semin. Immunol. 16, 3–9. https://doi.org/10.1016/j.smim.2003.10.003 (2004).
Kobayashi, K. et al. IRAK-M is a negative regulator of toll-like receptor signaling. Cell 110, 191–202. https://doi.org/10.1016/S0092-8674(02)00827-9 (2002).
Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107. https://doi.org/10.1038/nature08780 (2010).
Piccinini, A. M. & Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediat. Inflamm. 2010, 1–21. https://doi.org/10.1155/2010/672395 (2010).
Louhimo, J., Steer, M. L. & Perides, G. necroptosis is an important severity determinant and potential therapeutic target in experimental severe pancreatitis. Cell Mol. Gastroenterol. Hepatol. 2, 519–535. https://doi.org/10.1016/j.jcmgh.2016.04.002 (2016).
Bertheloot, D. & Latz, E. HMGB1, IL-1α, IL-33 and S100 proteins: Dual-function alarmins. Cell Mol. Immunol. 14, 43–64. https://doi.org/10.1038/cmi.2016.34 (2017).
Hoque, R. et al. TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology 141, 358–369. https://doi.org/10.1053/j.gastro.2011.03.041 (2011).
Gukovskaya, A. S. et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J. Clin. Investig. 100, 1853–1862. https://doi.org/10.1172/JCI119714 (1997).
Neuhöfer, P. et al. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A. Gastroenterology 144, 192–201. https://doi.org/10.1053/j.gastro.2012.09.058 (2013).
Sendler, M. et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis. Gastroenterology 158, 253-269.e14. https://doi.org/10.1053/j.gastro.2019.09.040 (2020).
Hoque, R. & Mehal, W. Z. Inflammasomes in pancreatic physiology and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G643-651. https://doi.org/10.1152/ajpgi.00388.2014 (2015).
Sharif, R. et al. Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut 58, 813–819. https://doi.org/10.1136/gut.2008.170423 (2009).
Medzhitov, R. et al. MyD88 Is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2, 253–258. https://doi.org/10.1016/S1097-2765(00)80136-7 (1998).
Freihat, L. A. et al. IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activity. Sci. Rep. 9, 15468. https://doi.org/10.1038/s41598-019-51913-3 (2019).
Zhou, H. et al. IRAK-M mediates toll-like receptor/IL-1R-induced NFκB activation and cytokine production. EMBO J. 32, 583–596. https://doi.org/10.1038/emboj.2013.2 (2013).
Gukovskaya, A. S. et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 122, 974–984. https://doi.org/10.1053/gast.2002.32409 (2002).
Westman, J., Grinstein, S. & Marques, P. E. Phagocytosis of necrotic debris at sites of injury and inflammation. Front. Immunol. 10, 3030. https://doi.org/10.3389/fimmu.2019.03030 (2020).
Gukovsky, I. et al. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275, G1402-1414. https://doi.org/10.1152/ajpgi.1998.275.6.G1402 (1998).
Algül, H. et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J. Clin. Investig. 117, 1490–1501. https://doi.org/10.1172/JCI29882 (2007).
Vanden Berghe, T. et al. Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135–147. https://doi.org/10.1038/nrm3737 (2014).
Wu, J. et al. Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury. EBioMedicine 58, 102920. https://doi.org/10.1016/j.ebiom.2020.102920 (2020).
Sendler, M. et al. Complement component 5 mediates development of fibrosis, via activation of stellate cells, in 2 mouse models of chronic pancreatitis. Gastroenterology 149, 765-776.e10. https://doi.org/10.1053/j.gastro.2015.05.012 (2015).
Glaubitz, J. et al. In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response. Nat. Commun. 13, 4502. https://doi.org/10.1038/s41467-022-32195-2 (2022).
Lee, B. et al. Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis. Gut 71, 1831–1842. https://doi.org/10.1136/gutjnl-2021-324546 (2022).
Peng, C. et al. Murine chronic pancreatitis model induced by partial ligation of the pancreatic duct encapsulates the profile of macrophage in human chronic pancreatitis. Front. Immunol. 13, 840887. https://doi.org/10.3389/fimmu.2022.840887 (2022).
Yang, D.-J. et al. MyD88 deficiency aggravates the severity of acute pancreatitis by promoting MyD88-independent TRIF pathway-mediated necrosis. Ann. Transl. Med. 10, 1214. https://doi.org/10.21037/atm-22-5134 (2022).
Zhang, H. et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J. Clin. Investig. 123, 1019–1031. https://doi.org/10.1172/JCI64931 (2013).
Qi-Xiang, M. et al. Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency. Gut Microbes 14, 2112882. https://doi.org/10.1080/19490976.2022.2112882 (2022).
Rothschild, D. E. et al. Enhanced mucosal defense and reduced tumor burden in mice with the compromised negative regulator IRAK-M. EBioMedicine 15, 36–47. https://doi.org/10.1016/j.ebiom.2016.11.039 (2017).
van Dijk, S. M. et al. Acute pancreatitis: recent advances through randomised trials. Gut 66, 2024–2032. https://doi.org/10.1136/gutjnl-2016-313595 (2017).
Sendler, M. et al. Cathepsin B activity initiates apoptosis via digestive protease activation in pancreatic acinar cells and experimental pancreatitis. J. Biol. Chem. 291, 14717–14731. https://doi.org/10.1074/jbc.M116.718999 (2016).
Niederau, C., Ferrell, L. D. & Grendell, J. H. Caerulein-induced acute necrotizing pancreatitis in mice: Protective effects of proglumide, benzotript, and secretin. Gastroenterology 88, 1192–1204. https://doi.org/10.1016/s0016-5085(85)80079-2 (1985).
Acknowledgements
The authors would like to thank Kathrin Gladrow, Diana Krüger, Susanne Wiche and Jenny Radel for their technical support.
Funding
Open Access funding enabled and organized by Projekt DEAL. This work was supported by Deutsche Forschungsgemeinschaft (DFG SE 2702/2–1, SE 2702/2–3, GRK 1947, GRK 2719, GL 1096/1–1), the PePPP center of excellence MV (ESF/14-BM-A55-0045/16).
Author information
Authors and Affiliations
Contributions
Concept of the study M.S., F.U.W., F.G.T. Data acquisition and interpretation: F.G.T., S.A., J.G., A.W. Writing committee M.S., F.U.W., J.G., F.G.T. Correction of manuscript and approval of final version: all.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Thiel, F.G., Asgarbeik, S., Glaubitz, J. et al. IRAK3-mediated suppression of pro-inflammatory MyD88/IRAK signaling affects disease severity in acute pancreatitis. Sci Rep 13, 10833 (2023). https://doi.org/10.1038/s41598-023-37930-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-37930-3
- Springer Nature Limited
This article is cited by
-
Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Journal of Nanobiotechnology (2024)